U.S. Resumes Giving Johnson And Johnson Vaccine With Warning

The video discusses the addition of a warning label to the COVID-19 vaccine due to rare blood clot concerns. The vaccine was paused for 11 days, but the CDC and FDA decided to resume its use, citing that the benefits outweigh the risks. The decision followed a thorough review by medical and scientific teams. The video also highlights that 15 women developed blood clots, with three fatalities, out of nearly 8 million Johnson and Johnson vaccine recipients.

What did the medical and scientific teams of the FDA and CDC review to reach their assessment?

What was the total number of people who received the Johnson and Johnson vaccine?